Sona Nanotech Inc (TSE:SONA)
:SONA
Want to see TSE:SONA full AI Analyst Report?
SONA Stock Chart & Stats
C$0.40
>-C$0.01(-2.00%)
At close: 4:00 PM EST
C$0.40
>-C$0.01(-2.00%)
Day’s Range― - ―
52-Week RangeC$0.29 - C$0.91
Previous CloseN/A
Volume36.80K
Average Volume (3M)124.26K
Market Cap
C$38.32M
Enterprise ValueC$37.46M
Total Cash (Recent Filing)C$36.55K
Total Debt (Recent Filing)C$318.31K
Price to Earnings (P/E)―
Beta0.94
Next Earnings
Jun 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding114,375,250
10 Day Avg. Volume87,178
30 Day Avg. Volume124,263
Financial Highlights & Ratios
PEG Ratio-2.88
Price to Book (P/B)-1.80K
Price to Sales (P/S)0.00
P/FCF Ratio-35.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.06
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Proprietary Nanorod TechnologySona's proprietary gold nanorod materials constitute a durable structural asset: unique nanoparticle IP that can be licensed or integrated into diagnostics and assays. That technology provides a long-term pathway to productization across life-science applications if R&D converts to commercial offerings.
Low Absolute Debt BurdenModest absolute debt reduces fixed creditor obligations and near-term default risk compared with highly leveraged peers. For a pre-revenue nanotech developer, low contractual debt helps preserve optionality to pursue product milestones before needing onerous debt financing.
Improved Cash Burn Vs 2021Management has shown capacity to reduce cash burn versus earlier periods, indicating operational discipline. If cost control is sustained, this structural improvement can extend runway and increase the odds that limited capital can fund key development or commercialization steps.
Bears Say
No Revenue / No Commercial ScaleThe company reports no revenue across multiple years, signaling lack of commercial validation. Without product sales, Sona remains dependent on external funding to progress development, creating persistent execution and financing risk until it achieves paying customers.
Persistent Net LossesSustained multi-year losses translate directly into cash outflows and erode resources required to commercialize technology. Persistent deficits increase the frequency and size of financing needs, raising dilution risk and constraining long-term investment in product development.
Negative Equity And Shrinking AssetsThe shift to negative shareholders' equity and falling assets materially weakens the balance sheet, reducing borrowing capacity and creditor confidence. This structural deterioration heightens insolvency and dilution risk and limits flexibility to fund commercialization or scale operations.
Sona Nanotech Inc News
SONA FAQ
What was Sona Nanotech Inc’s price range in the past 12 months?
Sona Nanotech Inc lowest stock price was C$0.29 and its highest was C$0.91 in the past 12 months.
What is Sona Nanotech Inc’s market cap?
Sona Nanotech Inc’s market cap is C$38.32M.
When is Sona Nanotech Inc’s upcoming earnings report date?
Sona Nanotech Inc’s upcoming earnings report date is Jun 25, 2026 which is in 33 days.
How were Sona Nanotech Inc’s earnings last quarter?
Currently, no data Available
Is Sona Nanotech Inc overvalued?
According to Wall Street analysts Sona Nanotech Inc’s price is currently Overvalued.
Does Sona Nanotech Inc pay dividends?
Sona Nanotech Inc does not currently pay dividends.
What is Sona Nanotech Inc’s EPS estimate?
Sona Nanotech Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sona Nanotech Inc have?
Sona Nanotech Inc has 114,375,250 shares outstanding.
What happened to Sona Nanotech Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Sona Nanotech Inc?
Currently, no hedge funds are holding shares in TSE:SONA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sona Nanotech Inc
Sona Nanotech Inc., nanotechnology life sciences company, manufactures and sells gold nanorod products for diagnostic tests. The company also provides Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic assay for the detection of the spike protein antigen from SARS-CoV-2 in saliva specimens from individuals, who are suspected of COVID-19; Gemini gold nanorods; Omni gold nanorods for medical applications; and contract services. Its products are used in various applications, including drug delivery, food and beverage testing, environmental testing, cell imaging, cancer treatment, and liposuction therapy, as well as medical and consumer, military, and veterinary diagnostics. The company is based in Halifax, Canada.
Technical Analysis
BioMark Diagnostics
―
Eastwood Bio-Medical Canada
―
StageZero Life Sciences Ltd
―
Medmira
―
ZYUS Life Sciences
―
Options Prices
Currently, No data available
---